| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1440-1797.2011.01512.X |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1797.2011.01512.x |
| https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1440-1797.2011.01512.x | ||
| P698 | PubMed publication ID | 21854505 |
| P2093 | author name string | Philip Clayton | |
| Blair S. Grace | |||
| Stephen P. McDonald | |||
| P2860 | cites work | Incidence of type 2 diabetes in Aboriginal Australians: an 11-year prospective cohort study | Q21260237 |
| Global and societal implications of the diabetes epidemic | Q29614551 | ||
| A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
| A note on robust variance estimation for cluster-correlated data | Q30600512 | ||
| An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. | Q33509778 | ||
| Renal disease in Australian Aborigines. | Q34025896 | ||
| Factors influencing reported rates of treated end-stage renal disease | Q36047329 | ||
| Analgesic nephropathy and renal replacement therapy in Australia: trends, comorbidities and outcomes | Q36662035 | ||
| Gender and human chronic renal disease | Q37131828 | ||
| Economics of type 1 diabetes | Q37781153 | ||
| Systematic care to reduce ethnic disparities in diabetes care | Q42665000 | ||
| The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study | Q43540904 | ||
| HbA1c screening for undiagnosed diabetes in New Zealand | Q44961749 | ||
| The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in Indigenous Australians | Q47215381 | ||
| Declining rates of coronary heart disease in New Zealand and Australia, 1983-1993. | Q50959127 | ||
| A randomized, controlled trial of early versus late initiation of dialysis | Q51685434 | ||
| Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia | Q52967198 | ||
| Renal disease and the environment: lessons from Aboriginal Australia * | Q57249888 | ||
| High mortality from renal disease and infection in Aboriginal central Australians with diabetes | Q57500387 | ||
| Haemodialysis outcomes of Aboriginal and Torres Strait Islander patients of remote Kimberley region origin | Q82230030 | ||
| Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales | Q82614574 | ||
| Ethnic differences in the natural progression of nephropathy among diabetes patients in New Zealand: hospital admission rate for renal complications, and incidence of end-stage renal disease and renal death | Q83817278 | ||
| Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease | Q84564036 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Australia | Q408 |
| New Zealand | Q664 | ||
| chronic renal insufficiency | Q736715 | ||
| P304 | page(s) | 76-84 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Nephrology | Q15750101 |
| P1476 | title | Increases in renal replacement therapy in Australia and New Zealand: Understanding trends in diabetic nephropathy | |
| P478 | volume | 17 |
| Q24201456 | Advance care planning for end-stage kidney disease |
| Q26471851 | Advance care planning for end-stage kidney disease |
| Q34781657 | Association between TNF-α -308G/A polymorphism and diabetic nephropathy risk: a meta-analysis |
| Q43439438 | Body mass index and postoperative complications in kidney transplant recipients |
| Q35858915 | C-Terminal Fragment of Agrin (CAF): A Novel Marker for Progression of Kidney Disease in Type 2 Diabetics |
| Q90298792 | Catalpol alleviates renal damage by improving lipid metabolism in diabetic db/db mice |
| Q38629322 | Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease |
| Q38494729 | Depression and diabetes: treatment and health-care delivery |
| Q38216851 | Diabetic kidney disease in Australia: current burden and future projections |
| Q51808999 | Dialysis outcomes of elderly Indigenous and non-Indigenous Australians |
| Q85366172 | Efficacy of a disease management program focused on acquisition of self-management skills in pre-dialysis patients with diabetic nephropathy: 24 months follow-up |
| Q64065696 | Elevated Platelet Galectin-3 and Rho-Associated Protein Kinase Activity Are Associated with Hemodialysis Arteriovenous Shunt Dysfunction among Subjects with Diabetes Mellitus |
| Q42279652 | End-stage renal disease epidemic in diabetics: is there light at the end of the tunnel? |
| Q44306229 | Endoplasmic reticulum stress response and inflammatory cytokines in type 2 diabetic nephropathy: Role of indoleamine 2,3-dioxygenase and programmed death-1 |
| Q38071780 | Epidemiology of Diabetic Kidney Disease |
| Q38747538 | Epigenetic Mechanisms in Diabetic Kidney Disease |
| Q37260201 | Estimated GFR reporting influences recommendations for dialysis initiation |
| Q39104901 | Gender differences in the dialysis treatment of Indigenous and non-Indigenous Australians. |
| Q35047036 | Incidence of renal replacement therapy for diabetic nephropathy in the Netherlands: Dutch diabetes estimates (DUDE)-3. |
| Q49843662 | Inequity in dialysis related practices and outcomes in Aotearoa/New Zealand: a Kaupapa Māori analysis |
| Q38420396 | Long-term effectiveness of a community-based model of care in Māori and Pacific patients with type 2 diabetes and chronic kidney disease: a 4-year follow up of the DElay Future End Stage Nephropathy due to Diabetes (DEFEND) study |
| Q34183178 | Meta‐analysis of the relationship between ACE I/D gene polymorphism and end‐stage renal disease in patients with diabetic nephropathy |
| Q26786923 | Non-Proteinuric Diabetic Nephropathy |
| Q37426953 | Pregnancy outcomes according to dialysis commencing before or after conception in women with ESRD. |
| Q44912222 | Psychosocial factors in people with chronic kidney disease prior to renal replacement therapy |
| Q42375197 | Social disparities in the prevalence of diabetes in Australia and in the development of end stage renal disease due to diabetes for Aboriginal and Torres Strait Islanders in Australia and Maori and Pacific Islanders in New Zealand. |
| Q35080873 | Survival advantage of peritoneal dialysis relative to hemodialysis in the early period of incident dialysis patients: a nationwide prospective propensity-matched study in Korea |
| Q26799468 | The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years |
| Q84805994 | Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia |
| Q57591266 | Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007–2011 |
| Q40231691 | Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress‑induced apoptosis. |
Search more.